Drugs Acting On The Blood Flashcards
Epoetin alfa indications
Anemia of chronic renal failure; in AIDS patient cancer related (epo should be <100u/l) Surgery Premature Zidovudine treatment
Most important regulator of the proliferation of committed progenitors and their immediate progeny
Erythropoetin
Epoetin alfa monitoring
Hiv & cancer patients: Hct 1x/week
Renal failure: 2x/week
Decrease dose if Hct inc >4pts
Epoetin alfa AE
Absolute or fxnal iron deficiency
Thromboembolic events
Cardio:inc bp, hypertensive encephalopathy, seizures
Myeloid growth factors
Gcsf gmcsf
By fibroblasts, endothelial cells, macrophages, T-cells
Gcsf used more since less toxic
Gm csf
Myelopoeisis,shorten neutropenia
Sq or iv, leukocyte count return to baseline 2-10 days
Low-neutrophilic, high-monocytosis and eosinophilia
Capillary leak syndrome with prolonged admin
G csf
Inc neutrophil by stimulating cfu g
Reduce episodes of febrile neutropenia
Ae produces marked granulocytosid and splenomegaly
Interleukin 11
For under chemo for nonmyeloid malignancies
Intestinal epithelial cell growth, osteoclastogenesis, inhibit adipogenesis
Ae:may require diuretics; blurred vision
Thrombopoetin
Recombinant human megakaryocyte growth and devt factor
PRIMARY regulator of platelet production
Produced by liver, marrow, stromal cells
Most common nutri disorder
Iron deficiency
Largest amt of dietary iron ingested by underprivileged
Nonheme iron
New erythrocytes
catabolized by RES
Sites of iron storage
Res, spleen, bone, intestinal mucosa cells, hepatocytes
Acts as natural ceiling and regulates absorption of iron
Small intestine
INDICATION of effectiveness of iron therapy
Inc reticulocyte count 4-7 days after
Inc hb/hct 3-4 weeks after treatment